Codagenix

Developer of live-attenuated viral vaccines using proprietary SAVE technology

placeStony Brook, New York, United States calendar_todayFounded 2011 groups41 employees language codagenix.com

Registered entities

Innovation

16 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 864 times.

YearFilings
20181
20193
20205
20216
20229
202312
202410
20256
20262

Investor mix

11 investors on record; lead investors include Adjuvant Capital, Topspin Fund, Euclidean Capital, Serum Institute of India.

Investor typeCountShare
Venture capital436%
Angel & family office19%
Other / undisclosed655%
Coming soon